Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: IMMEDICA PHARMA US INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2020-09-08 to 2025-07-31
Current total value of award: $33656933
Description: DEVELOPMENT OF INTRAVENOUS DRUG GANAXOLONE - UPDATE PRISM POP TO MATCH CONTRACT